Clinical trial
Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid…
NCT00074438 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00074438 |
|---|---|
| Title | Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis |
| Official title | Randomized, Multifactorial, Double-blind, Parallel-group, Dose-ranging Study of the Efficacy and Safety of Rituximab (MabThera®/Rituxan®) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis |
| Lead sponsor | Genentech, Inc., Industry |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | methotrexate, rituximab, corticosteroids, placebo |
| Enrollment | 465 |
| Start date | Jun 1, 2003 |
| Primary completion | Sep 1, 2004 |
| Completion | Jul 1, 2011 |
| First posted | Dec 15, 2003 |
| Last update posted | May 9, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: